Managing Toxicities from TKI EGFR and ALK Inhibitors

Managing Toxicities from TKI EGFR and ALK Inhibitors

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Jane Arboleda, APRN

Date of Release

May 14th, 2025